Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

238 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
European Society of Breast Imaging (EUSOBI) guidelines on the management of axillary lymphadenopathy after COVID-19 vaccination: 2023 revision.
Schiaffino S, Pinker K, Cozzi A, Magni V, Athanasiou A, Baltzer PAT, Camps Herrero J, Clauser P, Fallenberg EM, Forrai G, Fuchsjäger MH, Gilbert FJ, Helbich T, Kilburn-Toppin F, Kuhl CK, Lesaru M, Mann RM, Panizza P, Pediconi F, Sardanelli F, Sella T, Thomassin-Naggara I, Zackrisson S, Pijnappel RM. Schiaffino S, et al. Among authors: pinker k. Insights Imaging. 2023 Jul 19;14(1):126. doi: 10.1186/s13244-023-01453-2. Insights Imaging. 2023. PMID: 37466753 Free PMC article.
Molecular imaging for the characterization of breast tumors.
Magometschnigg HF, Helbich T, Brader P, Abeyakoon O, Baltzer P, Füger B, Wengert G, Polanec S, Bickel H, Pinker K. Magometschnigg HF, et al. Among authors: pinker k. Expert Rev Anticancer Ther. 2014 Jun;14(6):711-22. doi: 10.1586/14737140.2014.885383. Epub 2014 Feb 19. Expert Rev Anticancer Ther. 2014. PMID: 24552125 Review.
Improved diagnostic accuracy with multiparametric magnetic resonance imaging of the breast using dynamic contrast-enhanced magnetic resonance imaging, diffusion-weighted imaging, and 3-dimensional proton magnetic resonance spectroscopic imaging.
Pinker K, Bogner W, Baltzer P, Gruber S, Bickel H, Brueck B, Trattnig S, Weber M, Dubsky P, Bago-Horvath Z, Bartsch R, Helbich TH. Pinker K, et al. Invest Radiol. 2014 Jun;49(6):421-30. doi: 10.1097/RLI.0000000000000029. Invest Radiol. 2014. PMID: 24566292
Improved differentiation of benign and malignant breast tumors with multiparametric 18fluorodeoxyglucose positron emission tomography magnetic resonance imaging: a feasibility study.
Pinker K, Bogner W, Baltzer P, Karanikas G, Magometschnigg H, Brader P, Gruber S, Bickel H, Dubsky P, Bago-Horvath Z, Bartsch R, Weber M, Trattnig S, Helbich TH. Pinker K, et al. Clin Cancer Res. 2014 Jul 1;20(13):3540-9. doi: 10.1158/1078-0432.CCR-13-2810. Clin Cancer Res. 2014. PMID: 24963052
Introduction of an automated user-independent quantitative volumetric magnetic resonance imaging breast density measurement system using the Dixon sequence: comparison with mammographic breast density assessment.
Wengert GJ, Helbich TH, Vogl WD, Baltzer P, Langs G, Weber M, Bogner W, Gruber S, Trattnig S, Pinker K. Wengert GJ, et al. Among authors: pinker k. Invest Radiol. 2015 Feb;50(2):73-80. doi: 10.1097/RLI.0000000000000102. Invest Radiol. 2015. PMID: 25333307 Clinical Trial.
238 results